Notes / Company

Hemo Organic Ltd.

HEMORGANIC BSE 524590 ISIN INE422G01015 Pharmaceuticals

Fundamentals

Market cap: ₹6.64 cr
P/E: 65.07×
ROE: 0.00%
Debt / equity: -9.77
52-week range: 8.08 — 22.51

The timeline — 1 note on Hemo Organic Ltd.

May 2026

29 May 26 · 7:34 PM IST Brief

Brief · Earnings · Micro cap

Hemo Organic's revenue drops 63% and auditors qualify the accounts

The company swung to a ₹77.81 lakh net loss as revenue collapsed and auditors again flagged missing documentation for trade receivables.

Verify on exchange BSE filings for HEMORGANIC NSE filings for HEMORGANIC